🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This research study is studying an investigational drug, NC318, as a possib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-06
Trial ID
NCT04430933
Treatments Being Tested
This is a prospective, multicenter, randomized, uncontrolled Phase II study...
Status
Recruiting
Location
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2024-09-24
Trial ID
NCT06775275
Treatments Being Tested
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
Phase Ib study to evaluate the tolerability, safety, pharmacokinetics and p...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-27
Trial ID
NCT07381829
Treatments Being Tested
The purpose of this study is to evaluate BMS-986442 in combination with niv...
Status
Terminated
Location
Mayo Clinic in Arizona - Phoenix
Start Date
2022-10-04
Trial ID
NCT05543629
Treatments Being Tested
This is a pilot study looking at using stereotactic radiosurgery and full d...
Status
Unknown
Location
MD Anderson Cancer Center at Cooper
Start Date
2013-10
Trial ID
NCT02568033
Treatments Being Tested
The main purpose of the study is to examine if periadjuvant (neoadjuvant, t...
Status
Active Not Recruiting
Location
Local Institution - 0104
Start Date
2019-11-05
Trial ID
NCT04025879
Treatments Being Tested
This study was conducted to compare the activities of erlotinib to that of ...
Status
Terminated
Location
Lovelace Medical Group
Start Date
2006-07
Trial ID
NCT00391586
Treatments Being Tested